Literature DB >> 15817485

Identification of a subversive substrate of Trichomonas vaginalis purine nucleoside phosphorylase and the crystal structure of the enzyme-substrate complex.

Yang Zang1, Wen-Hu Wang, Shaw-Wen Wu, Steven E Ealick, Ching C Wang.   

Abstract

Trichomonas vaginalis is an anaerobic protozoan parasite that causes trichomoniasis, a common sexually transmitted disease with worldwide impact. One of the pivotal enzymes in its purine salvage pathway, purine nucleoside phosphorylase (PNP), shows physical properties and substrate specificities similar to those of the high molecular mass bacterial PNPs but differing from those of human PNP. While carrying out studies to identify inhibitors of T. vaginalis PNP (TvPNP), we discovered that the nontoxic nucleoside analogue 2-fluoro-2'-deoxyadenosine (F-dAdo) is a "subversive substrate." Phosphorolysis by TvPNP of F-dAdo, which is not a substrate for human PNP, releases highly cytotoxic 2-fluoroadenine (F-Ade). In vitro studies showed that both F-dAdo and F-Ade exert strong inhibition of T. vaginalis growth with estimated IC(50) values of 106 and 84 nm, respectively, suggesting that F-dAdo might be useful as a potential chemotherapeutic agent against T. vaginalis. To understand the basis of TvPNP specificity, the structures of TvPNP complexed with F-dAdo, 2-fluoroadenosine, formycin A, adenosine, inosine, or 2'-deoxyinosine were determined by x-ray crystallography with resolutions ranging from 2.4 to 2.9 A. These studies showed that the quaternary structure, monomer fold, and active site are similar to those of Escherichia coli PNP. The principal active site difference is at Thr-156, which is alanine in E. coli PNP. In the complex of TvPNP with F-dAdo, Thr-156 causes the purine base to tilt and shift by 0.5 A as compared with the binding scheme of F-dAdo in E. coli PNP. The structures of the TvPNP complexes suggest opportunities for further improved subversive substrates beyond F-dAdo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817485     DOI: 10.1074/jbc.M501843200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Susceptibility in vitro of clinically metronidazole-resistant Trichomonas vaginalis to nitazoxanide, toyocamycin, and 2-fluoro-2'-deoxyadenosine.

Authors:  Janelle M Wright; Linda A Dunn; Zygmunt Kazimierczuk; Anita G Burgess; Kenia G Krauer; Peter Upcroft; Jacqueline A Upcroft
Journal:  Parasitol Res       Date:  2010-06-09       Impact factor: 2.289

2.  Inhibition and structure of Trichomonas vaginalis purine nucleoside phosphorylase with picomolar transition state analogues.

Authors:  Agnes Rinaldo-Matthis; Corin Wing; Mahmoud Ghanem; Hua Deng; Peng Wu; Arti Gupta; Peter C Tyler; Gary B Evans; Richard H Furneaux; Steven C Almo; Ching C Wang; Vern L Schramm
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

3.  Coordinated Biosynthesis of the Purine Nucleoside Antibiotics Aristeromycin and Coformycin in Actinomycetes.

Authors:  Gudan Xu; Liyuan Kong; Rong Gong; Liudong Xu; Yaojie Gao; Ming Jiang; You-Sheng Cai; Kui Hong; Youcai Hu; Peng Liu; Zixin Deng; Neil P J Price; Wenqing Chen
Journal:  Appl Environ Microbiol       Date:  2018-10-30       Impact factor: 4.792

4.  Structural basis of the substrate specificity of Bacillus cereus adenosine phosphorylase.

Authors:  Paola Dessanti; Yang Zhang; Simone Allegrini; Maria Grazia Tozzi; Francesco Sgarrella; Steven E Ealick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-02-14

5.  Crystal structure of Escherichia coli purine nucleoside phosphorylase in complex with 7-deazahypoxanthine.

Authors:  Vladimir I Timofeev; Nadezhda E Zhukhlistova; Yuliya A Abramchik; Ilya I Fateev; Maria A Kostromina; Tatiana I Muravieva; Roman S Esipov; Inna P Kuranova
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2018-05-23       Impact factor: 1.056

6.  Humanized ADEPT comprised of an engineered human purine nucleoside phosphorylase and a tumor targeting peptide for treatment of cancer.

Authors:  Sepideh Afshar; Tsuneaki Asai; Sherie L Morrison
Journal:  Mol Cancer Ther       Date:  2009-01       Impact factor: 6.261

7.  Characterization of 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidases from Borrelia burgdorferi: Antibiotic targets for Lyme disease.

Authors:  Kenneth A Cornell; Reece J Knippel; Gerald R Cortright; Meghan Fonken; Christian Guerrero; Amy R Hall; Kristen A Mitchell; John H Thurston; Patrick Erstad; Aoxiang Tao; Dong Xu; Nikhat Parveen
Journal:  Biochim Biophys Acta Gen Subj       Date:  2019-10-31       Impact factor: 3.770

8.  Deazapurine Nucleoside Analogues for the Treatment of Trichomonas vaginalis.

Authors:  Manal J Natto; Fabian Hulpia; Eric R Kalkman; Susan Baillie; Amani Alhejeli; Yukiko Miyamoto; Lars Eckmann; Serge Van Calenbergh; Harry P de Koning
Journal:  ACS Infect Dis       Date:  2021-05-11       Impact factor: 5.578

9.  Natural Products as New Treatment Options for Trichomoniasis: A Molecular Docking Investigation.

Authors:  Mary Snow Setzer; Kendall G Byler; Ifedayo Victor Ogungbe; William N Setzer
Journal:  Sci Pharm       Date:  2017-01-27

10.  Insights into phosphate cooperativity and influence of substrate modifications on binding and catalysis of hexameric purine nucleoside phosphorylases.

Authors:  Priscila O de Giuseppe; Nadia H Martins; Andreia N Meza; Camila R dos Santos; Humberto D'Muniz Pereira; Mario T Murakami
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.